Laurus Labs.
Indian pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 35
What's happening
Earlier this month
-
Stocks of Dixon Technologies, Kotak Mahindra Bank, and Laurus Labs hit a fresh 52-week high on November 1, 2026.Some support1 report
-
Stock prices for Bank of Maharashtra, Urban Company, and Laurus Labs saw significant gains on October 31, 2026.Some support1 report
-
CDMO businesses are benefiting from higher commercial demand, leading to heavy investment in new manufacturing capacity.Some support1 report
-
Laurus Labs operationalized a peptide manufacturing facility in Visakhapatnam.Some support2 reports
-
Laurus Labs proposed acquiring stakes in two companies and Motilal Oswal maintained a Buy rating on the stock.Some support1 report
-
A market report details significant stock rallies across several Indian companies, including PVR Inox, Laurus Labs, and Bharti Airtel.Some support1 report
-
Coal India and Laurus Labs are key subjects for their upcoming Q2 earnings reports.Some support1 report
-
Brokerage firms provided ratings and analyzed the diversification trends within Indian pharmaceutical supply chains.Some support1 report1 development inside
-
Laurus Labs is shifting focus from building to filling capacity and may participate in Amgen's supply chain.Some support1 report
One to three months ago
-
Pharma shares are gaining in demand, affecting major companies including Wockhardt, Biocon, Torrent Pharmaceuticals, and Laurus Labs.Some support1 report
-
Laurus Labs is based in Hyderabad.Some support1 report
-
MSCI is reviewing Indian companies, leading to potential upgrades and removal risks for stocks like SBI Cards, Biocon, and Laurus Labs.Well supported9 reports4 developments inside
-
MSCI announced the index review inclusion of constituents, including Adani Energy Solutions and Laurus Labs, on August 31, 2026.Some support3 reports1 development inside
-
MSCI is reviewing Indian companies, with high probability for inclusion in the MSCI India Standard Index for several firms.Some support2 reports4 developments inside
-
Stock targets indicate strong buying trend for Laurus Labs and Glenmark Pharmaceuticals.Some support1 report
-
Cipla, Ipca Laboratories, and Laurus Labs operate as major finished dosage manufacturers in the growing Indian pharma market.Some support3 reports
Gone quiet
No new reports in 90+ days-
Laurus Labs rose over 100% and Ather Energy surged over 200% on August 1, while Inox Wind, KEC International, and Reliance Power were listed among Nifty 500 laggards.Some support1 report
-
Indian stock indices rose over 2% on August 1, 2026, with Laurus Labs, Ashok Leyland, and Swiggy leading gains.Some support1 report
-
Citigroup upgraded the stock target price for Laurus Labs.Some support1 report
-
Laurus Labs' founder announced the company achieved record quarterly revenue.Some support1 report
-
Vinod Nair noted that the market exemplifies a mid-cap premium valuation pattern.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Laurus Labs
Events traced to Laurus Labs, step by step, newest firstAround Laurus Labs this week
News at the entities that move Laurus Labs most-
MSCI StructuralMSCI index decision affects Strategy Inc. status.Moves Laurus Labs
-
Motilal Oswal Mentioned togetherMotilal Oswal and Nomura reported strong sales and profit growth while reviewing 134 companies in India.Moves Laurus Labs
-
founder StructuralHFS Research, led by a founder, collaborated with Rackspace on research identifying barriers to AI adoption.Moves Laurus Labs
-
Visakhapatnam Shared contextA UAE delegation met with shrimp processing companies in Visakhapatnam to discuss import opportunities for aquaculture products.Moves Laurus Labs
-
Kotak Mahindra Bank Mentioned togetherNippon India Small Cap Fund made various stake adjustments, including exiting Fineotex Chemical and increasing holdings in Tata Steel and Kotak Mahindra Bank.Moves Laurus Labs
-
Coal India Mentioned togetherCoal India and Tata Steel are competing for raw material market share, with Coal India seeking an iron ore block in the state of Odisha.Moves Laurus Labs
Connections
The 20 strongest of 35, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MSCI Structural
MSCI formally included Laurus Labs in its global and India standard indices, resulting in an upgrade status.
-
founder Structural
The founder holds a leadership role within the company, which provides the operational base for the founder's professional function.
-
Motilal Oswal Mentioned together
Motilal Oswal provided a Buy rating on Laurus Labs stock.
-
Banks Mentioned together
The relationship is noted in a single snapshot as being connected through a shared focus on the pharmaceuticals sector.
-
Visakhapatnam Shared context
Laurus Labs operates a peptide manufacturing facility located in Visakhapatnam.
-
Kotak Mahindra Bank Mentioned together
Both Kotak Mahindra Bank and Laurus Labs were reported as hitting fresh 52-week highs simultaneously.
-
Ajanta Pharma Mentioned together
Both companies are mentioned together in the context of a rally within the pharmaceutical stocks sector.
-
Coal India Mentioned together
Both firms were mentioned together in the context of Q2 earnings reports.
Show all 20 connections
-
Aurobindo Pharma Mentioned together
Both companies are noted for their continued strength within the pharmaceutical sector.
-
Ipca Laboratories Mentioned together
Both companies are mentioned as participants in the growth of the CDMO and Affordable Medicine sectors.
-
Cipla Mentioned together
The entities are co-mentioned in the context of sector performance comparisons within the pharmaceutical industry.
-
Vinod Nair Mentioned together
The entities are discussed as examples of a mid-cap premium valuation pattern in the market.
-
Torrent Pharmaceuticals Mentioned together
Both companies operate within the pharmaceutical sector which is currently experiencing market demand and share price increases.
-
Persistent Systems Mentioned together
Both companies are identified as providers in the technology and pharma service sectors.
-
Infosys Mentioned together
Both companies are co-mentioned as highly active stocks listed on the NSE.
-
Mumbai Shared context
The company's financial performance is observed within the context of the city.
-
Hyderabad Shared context
Laurus Labs is located in and conducts business within the city of Hyderabad.
-
Amgen Structural
Laurus Labs is forecasted to potentially participate in Amgen's supply chain.
-
Supetar Mentioned together
The relationship is undefined as the single snapshot refers ambiguously to a generic 'Company' candidate for index upgrade.
-
Capex Mentioned together
The single snapshot describes an internal strategic shift of Laurus Labs and does not mention Capex.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
8 events- Stock prices for Bank of Maharashtra, Urban Company, and Laurus Labs saw significant gains on October 31, 2026.
- CDMO businesses are benefiting from higher commercial demand, leading to heavy investment in new manufacturing capacity.
- Laurus Labs operationalized a peptide manufacturing facility in Visakhapatnam.
- Laurus Labs proposed acquiring stakes in two companies and Motilal Oswal maintained a Buy rating on the stock.
- A market report details significant stock rallies across several Indian companies, including PVR Inox, Laurus Labs, and Bharti Airtel.
- Coal India and Laurus Labs are key subjects for their upcoming Q2 earnings reports.
- Brokerage firms provided ratings and analyzed the diversification trends within Indian pharmaceutical supply chains.
- Laurus Labs is shifting focus from building to filling capacity and may participate in Amgen's supply chain.
September 2026
2 eventsShow 3 earlier months
August 2026
5 events- MSCI announced the index review inclusion of constituents, including Adani Energy Solutions and Laurus Labs, on August 31, 2026.
- Stock targets indicate strong buying trend for Laurus Labs and Glenmark Pharmaceuticals.
- Cipla, Ipca Laboratories, and Laurus Labs operate as major finished dosage manufacturers in the growing Indian pharma market.
- Laurus Labs rose over 100% and Ather Energy surged over 200% on August 1, while Inox Wind, KEC International, and Reliance Power were listed among Nifty 500 laggards.
- Indian stock indices rose over 2% on August 1, 2026, with Laurus Labs, Ashok Leyland, and Swiggy leading gains.